Shine Medical Technologies, a developer of medical isotopes and cancer treatment elements, intends to build a new manufacturing plant in Janesville, Wis. Plant completion is planned for 2015, with more than 100 permanent employees and potential for further employment growth.
A new study has found that a “soil and seed” approach may offer a simple and effective treatment for patients with metastatic solid tumors of visceral organs such as the liver, kidney, lung and brain. The study is published in the September issue of Radiology.
Written by Lisa Fratt
Microscopic gold particles could multiply the effectiveness of standard cancer radiation therapy by acting as tiny missiles that destroy blood vessels feeding cancerous tumors. Early research about this method, which could shorten cancer treatment and make it more effective, is being presented at the 2011 Joint Meeting of the American Association of Physicists in Medicine (AAPM) and Canadian Organization of Medical Physicists (COMP).
Two tiny genetic variations can predict which patients with Hodgkin's lymphoma are most likely to develop radiation-induced second cancers years after treatment, according to a genome-wide association study (GWAS) published online July 24 in Nature Medicine. Knowing in advance who is at risk could help physicians tailor treatment to reduce the risks for patients who are most susceptible to long-term damage.
Roswell Park Cancer Institute in Buffalo, N.Y., has been named a Center of Quantitative Imaging Excellence by the National Cancer Institute (NCI).
Molecular radiotherapy needs an injection of research and funding to broaden its usage and expand its effectiveness as a minimally invasive method of cancer treatment, according to an April report released by the British Institute of Radiology (BIR).
Overall cancer incidence in the U.S. decreased by nearly 1 percent per year between 2003 and 2007, with mortality falling by twice that figure across all four years, thanks largely to advances in diagnostic imaging, showed the findings of a report published in the April edition of the Journal of the National Cancer Institute.
Regional and local characterization of 18F-FDG PET tracer heterogeneity in tumors are more powerful than global measurements currently used in clinical practice, which means they could hold "the potential to revolutionize the predictive role of PET in cancer treatment,” according to research published in the March issue of the Journal of Nuclear Medicine.
Tokamak Solutions has received more than $323,000 in contracts and investments toward the development of a super compact tokamak, a fusion neutron source, in part for the production of medical isotopes for the diagnosis and treatment of cancers.
|
|
|
|
RSS 
